OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Clinical pharmacological innovation in the treatment of depression
Jeffrey M. Witkin, Lalit K. Golani, Jodi L. Smith
Expert Review of Clinical Pharmacology (2023) Vol. 16, Iss. 4, pp. 349-362
Closed Access | Times Cited: 13

Showing 13 citing articles:

(R)-(-)-Ketamine: The Promise of a Novel Treatment for Psychiatric and Neurological Disorders
Hana Shafique, Julie Demers, Julia Biesiada, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 12, pp. 6804-6804
Open Access | Times Cited: 9

Amplification of the therapeutic potential of AMPA receptor potentiators from the nootropic era to today
Daniel P. Radin, Arnold S. Lippa, Sabhya Rana, et al.
Pharmacology Biochemistry and Behavior (2025) Vol. 248, pp. 173967-173967
Closed Access

PPARβ/δ Activation Improves Corticosterone‐Induced Oxidative Stress Damage in Astrocytes by Targeting UBR5/ATM Signaling
Juan Ji, Y. Chen, Chen Hong, et al.
Journal of Neurochemistry (2025) Vol. 169, Iss. 2
Closed Access

Safety in treatment: Classical pharmacotherapeutics and new avenues for addressing maternal depression and anxiety during pregnancy
Merel Dagher, Catherine M. Cahill, Anne M. Andrews
Pharmacological Reviews (2025) Vol. 77, Iss. 3, pp. 100046-100046
Closed Access

Is there a continued need for behavioral pharmacology in the discovery and development of medicines?
Jeffrey M. Witkin, Jodi L. Smith, Daniel P. Radin
Journal of Pharmacology and Experimental Therapeutics (2025), pp. 103571-103571
Closed Access

Potentiation of AMPA receptors for rapid therapeutic gain in psychiatry has reached a new level of excitement
Jeffrey M. Witkin, Arnold S. Lippa
Neuropsychopharmacology (2023) Vol. 49, Iss. 1, pp. 339-340
Closed Access | Times Cited: 5

Ketamine – An Imperfect Wonder Drug?
Tanner Magruder, Marielle Isenhart, Maximillian V Striepe, et al.
Biochemical Pharmacology (2024) Vol. 229, pp. 116516-116516
Closed Access | Times Cited: 1

ShuYu capsule alleviates emotional and physical symptoms of premenstrual dysphoric disorder: Impact on ALLO decline and GABAA receptor δ subunit in the PAG area
Xiwen Geng, Xinyu Wang, Kun Liu, et al.
Phytomedicine (2024) Vol. 130, pp. 155549-155549
Closed Access | Times Cited: 1

Inflammaging, Immunosenescence, and Anti-Inflammatory Medications Used in Psychiatry: A Brief Overview
Karan Kverno
Journal of Psychosocial Nursing and Mental Health Services (2023) Vol. 61, Iss. 5, pp. 7-10
Closed Access | Times Cited: 1

A synopsis of multitarget therapeutic effects of anesthetics on depression
Guowei Wu, Hongwei Xu
European Journal of Pharmacology (2023) Vol. 957, pp. 176032-176032
Closed Access

Page 1

Scroll to top